Finally, we assessed the effect of enhanced hypoxic signaling on tumor angiogenesis (measured by CD31-positive cells) and observed a surprising relative decrease in CD31-positive cells, suggesting reduced angiogenic signaling (Figures 4D and 4H). This evidence concerns the gene PECAM1 and neoplasm.